The presence of the previous case, together with the case presented in the current study, suggest that autoimmune diseases can occur in patients with IRAK4 deficiency in conflict with the paradigm of IRAK4-mediated signaling being critically necessary for the development of reactive autoantibodies and autoimmune diseases. Here, IRAK4 is linked to autoimmune disease.